These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16944094)

  • 1. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.
    Currie CJ; Poole CD; Woehl A; Morgan CL; Cawley S; Rousculp MD; Covington MT; Peters JR
    Diabetologia; 2006 Oct; 49(10):2272-80. PubMed ID: 16944094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.
    Currie CJ; Poole CD; Woehl A; Morgan CL; Cawley S; Rousculp MD; Covington MT; Peters JR
    Diabet Med; 2007 Feb; 24(2):187-94. PubMed ID: 17257282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
    Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
    Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument.
    Vileikyte L; Peyrot M; Bundy C; Rubin RR; Leventhal H; Mora P; Shaw JE; Baker P; Boulton AJ
    Diabetes Care; 2003 Sep; 26(9):2549-55. PubMed ID: 12941717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional status mediates the association between peripheral neuropathy and health-related quality of life in individuals with diabetes.
    Riandini T; Wee HL; Khoo EYH; Tai BC; Wang W; Koh GCH; Tai ES; Tavintharan S; Chandran K; Hwang SW; Venkataraman K
    Acta Diabetol; 2018 Feb; 55(2):155-164. PubMed ID: 29185052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
    Vinik EJ; Hayes RP; Oglesby A; Bastyr E; Barlow P; Ford-Molvik SL; Vinik AI
    Diabetes Technol Ther; 2005 Jun; 7(3):497-508. PubMed ID: 15929681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health state preference assessment in diabetic peripheral neuropathy.
    Sullivan SD; Lew DP; Devine EB; Hakim Z; Reiber GE; Veenstra DL
    Pharmacoeconomics; 2002; 20(15):1079-89. PubMed ID: 12456202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy.
    Lewko J; Polityńska B; Kochanowicz J; Zarzycki W; Okruszko A; Sierakowska M; Jankowiak B; Górska M; Krajewska-Kułak E; Kowalczuk K
    Adv Med Sci; 2007; 52 Suppl 1():144-6. PubMed ID: 18229653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy.
    Sadosky A; Mardekian J; Parsons B; Hopps M; Bienen EJ; Markman J
    J Diabetes Complications; 2015 Mar; 29(2):212-7. PubMed ID: 25498300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing health-related quality of life in diabetes.
    Coffey JT; Brandle M; Zhou H; Marriott D; Burke R; Tabaei BP; Engelgau MM; Kaplan RM; Herman WH
    Diabetes Care; 2002 Dec; 25(12):2238-43. PubMed ID: 12453967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence: Correlation with measures of diabetic sensorimotor neuropathy.
    Stirban AO; Bondor CI; Florea B; Veresiu IA; Gavan NA
    J Diabetes Complications; 2018 Sep; 32(9):851-856. PubMed ID: 30025785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy: comparison with chronic osteoarthritis.
    Cho YW; Na GY; Lim JG; Kim SH; Kim HS; Earley CJ; Allen RP
    Sleep Med; 2013 Dec; 14(12):1387-92. PubMed ID: 24210603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.
    Gore M; Brandenburg NA; Hoffman DL; Tai KS; Stacey B
    J Pain; 2006 Dec; 7(12):892-900. PubMed ID: 17157775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).
    Cabezas-Cerrato J
    Diabetologia; 1998 Nov; 41(11):1263-9. PubMed ID: 9833931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.
    Gore M; Brandenburg NA; Dukes E; Hoffman DL; Tai KS; Stacey B
    J Pain Symptom Manage; 2005 Oct; 30(4):374-85. PubMed ID: 16256902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002--results from the Diabetic Microvascular Complications (DIMICO) study.
    Happich M; John J; Stamenitis S; Clouth J; Polnau D
    Diabetes Res Clin Pract; 2008 Aug; 81(2):223-30. PubMed ID: 18602714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.